Medicamen Biotech

Medicamen Biotech FCF per Share

The Free Cash Flow per Share of Medicamen Biotech (MEDICAMEQ.NS) as of Oct 19, 2026 is -29.28 INR. In the previous year, Free Cash Flow per Share was -8.80 INR — a change of 232.79% (lower).

FCF per Share

-29.28INR

YoY

232.79%

Last updated:

Free Cash Flow per Share of Medicamen Biotech is 2026 -29.28 INR. Free Cash Flow per Share of Medicamen Biotech was 2025 -8.80 INR. It decreases by 232.79% lower compared to the previous year.

The Medicamen Biotech FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-9.43 INR
Jan 1, 2020
-20.33 INR
Jan 1, 2021
-4.25 INR
Jan 1, 2022
-3.56 INR
Jan 1, 2023
-10.19 INR
Jan 1, 2024
-10.26 INR
Jan 1, 2025
-8.80 INR
Jan 1, 2026
-29.28 INR
The Medicamen Biotech FCF per Share history
YEARFCF per ShareYoY
-29.28INR+232.79%
-8.80INR-14.23%
-10.26INR+0.64%
-10.19INR+186.59%
-3.56INR-16.28%
-4.25INR-79.10%
-20.33INR+115.47%
-9.43INR-19.27%
-11.69INR-1,147.43%
1.12INR-79.00%
5.31INR-256.54%
-3.39INR-173.45%
4.62INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicamen Biotech Stock analysis

What does Medicamen Biotech do? Medicamen Biotech Ltd, based in New Delhi, India, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and markets diverse pharmaceutical formulations, including oral solids, liquids, ointments, and injectables for both non-oncology and oncology treatments. It focuses on oncology therapeutics, cardiology, central nervous system disorders, diabetology, and pain management. With 388 employees, Medicamen Biotech produces a range of products such as tablets, capsules, syrups, and specialized oncology drugs like Abiraterone acetate and Imatinib mesylate. Medicamen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicamen Biotech stock

Free Cash Flow per Share of Medicamen Biotech is -29.28 INR in 2026.

Free Cash Flow per Share of Medicamen Biotech changed from -8.80 INR to -29.28 INR, representing a 232.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Medicamen Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Medicamen Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Medicamen Biotech